Cogent Biosciences, INC. (COGT) — 8-K Filings

All 8-K filings from Cogent Biosciences, INC.. Browse 18 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (18)

8-K Filing — Dec 8, 2025
Cogent Biosciences Enters Material Definitive Agreement — Nov 18, 2025 Risk: medium
On November 18, 2025, Cogent Biosciences, Inc. entered into a material definitive agreement. This filing also indicates the creation of a direct financial oblig
8-K Filing — Nov 13, 2025
Cogent Biosciences Files 8-K Report — Nov 10, 2025 Risk: low
On November 10, 2025, Cogent Biosciences, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, along with other events and
Cogent Biosciences Files 8-K on Financials — Nov 3, 2025 Risk: low
Cogent Biosciences, Inc. filed an 8-K on November 3, 2025, reporting on its results of operations and financial condition. The filing includes financial stateme
Cogent Biosciences Enters Material Agreement, Files 8-K — Sep 11, 2025 Risk: medium
On September 5, 2025, Cogent Biosciences, Inc. entered into a material definitive agreement. This filing also indicates the creation of a direct financial oblig
Cogent Biosciences Files 8-K on Financials — Aug 5, 2025 Risk: low
Cogent Biosciences, Inc. filed an 8-K on August 5, 2025, reporting on its results of operations and financial condition. The filing also includes financial stat
Cogent Biosciences Files 8-K: Material Agreement & Financials — Jul 10, 2025 Risk: medium
On July 7, 2025, Cogent Biosciences, Inc. entered into a material definitive agreement. The company also reported its results of operations and financial condit
Cogent Biosciences Files 8-K: Other Events Reported — Jul 7, 2025 Risk: medium
On July 7, 2025, Cogent Biosciences, Inc. filed an 8-K report. The filing indicates an 'Other Events' item, suggesting a significant, non-routine event has occu
Cogent Biosciences Files 8-K: Material Agreement & Financial Obligation — Jun 11, 2025 Risk: medium
On June 11, 2025, Cogent Biosciences, Inc. entered into a material definitive agreement, likely related to financing or a significant business transaction. This
Cogent Biosciences Files 8-K with Corporate Updates — Jun 5, 2025 Risk: low
Cogent Biosciences, Inc. filed an 8-K on June 5, 2025, reporting on events that occurred on June 4, 2025. The filing indicates amendments to articles of incorpo
Pfizer to Acquire Cogent Biosciences for $6.7 Billion — Dec 9, 2024 Risk: medium
Cogent Biosciences, Inc. announced on December 8, 2024, that it has entered into a definitive agreement to be acquired by Pfizer Inc. The transaction is valued
Cogent Biosciences Files 8-K — Sep 3, 2024 Risk: low
Cogent Biosciences, Inc. filed an 8-K on September 3, 2024, reporting other events and financial statements. The company, formerly Unum Therapeutics Inc., is in
Cogent Biosciences Files 8-K Report — Jun 27, 2024 Risk: low
On June 27, 2024, Cogent Biosciences, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits." It also no
Cogent Biosciences Files 8-K — Jun 5, 2024 Risk: low
Cogent Biosciences, Inc. filed an 8-K on June 5, 2024, reporting on matters submitted to a vote of security holders and financial statements. The company, forme
Cogent Biosciences Reports Unregistered Equity Sales — Mar 22, 2024 Risk: medium
Cogent Biosciences, Inc. filed an 8-K on March 21, 2024, reporting unregistered sales of equity securities. The company, formerly Unum Therapeutics Inc., is inc
Cogent Biosciences Files 8-K on Financial Condition — Feb 26, 2024 Risk: low
Cogent Biosciences, Inc. filed an 8-K on February 26, 2024, reporting on its results of operations and financial condition. The filing indicates the company's c
Cogent Biosciences Files 8-K on Material Agreement & Equity Sales — Feb 14, 2024 Risk: medium
Cogent Biosciences, Inc. filed an 8-K on February 14, 2024, reporting events that occurred on February 13, 2024. The filing indicates the company entered into a

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX